Recruiting completed
Phase 2, Phase 3
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

This is a single-arm, open-label, multi-site, single-dose Phase 1/2/3 study in subjects with severe sickle cell disease (SCD). The study will evaluate the safety and efficacy of autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCs) using CTX001.

ClinicalTrials.gov Identifier
NCT03745287
Eligibility criteria
Sex
Age
12 Years - 35 Years
Phase
2, 3
Key inclusion criteria
  • Diagnosis of severe sickle cell disease as defined by:
  • Documented severe sickle cell disease genotype
  • History of at least two severe vaso-occlusive crisis events per year for the previous two years prior to enrollment
  • Eligible for autologous stem cell transplant as per investigators judgment
Key exclusion criteria
  • An available 10/10 human leukocyte antigen (HLA)-matched related donor
  • Prior hematopoietic stem cell transplant (HSCT)
  • Clinically significant and active bacterial, viral, fungal, or parasitic infection
Other protocol defined inclusion/exclusion criteria may apply.
Trial details
Condition
Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
Study duration
November 2018 - October 2024
Study type
Interventional
Intervention/Treatment
Biological : CTX001
Estimated enrollment
45

Interested in this trial?

CONTACT US

About clinical trials

Volunteers who participate in clinical trials help make new medicines a reality. Clinical trials are carefully designed research studies in humans that evaluate the safety and efficacy of an investigational medicine.

If you’re interested in participating in a Vertex clinical trial, we encourage you to speak with your health care provider first about what’s involved and your eligibility. 

See FAQS

Location
x
  • Recruiting completed
    1
    Lucille Packard Children's Hospital of Stanford University
    Palo Alto California 94304 United States
  • Recruiting completed
    1
    Ann & Robert Lurie Children's Hospital of Chicago
    Chicago Illinois 60611 United States
  • Recruiting completed
    1
    University of Illinois at Chicago Hospitals and Health Systems
    Chicago Illinois 60612 United States
  • Recruiting completed
    1
    Columbia University Medical Center (21+ years)
    New York New York 10032 United States
  • Recruiting completed
    1
    Columbia University Medical Center (≤21 years)
    New York New York 10032 United States
  • Recruiting completed
    1
    Children's Hospital of Philadelphia
    Philadelphia Pennsylvania 19104 United States
  • Recruiting completed
    1
    St. Jude Children's Research Hospital
    Memphis Tennessee 38105 United States
  • Recruiting completed
    1
    The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
    Nashville Tennessee 37203 United States
  • Recruiting completed
    1
    Methodist Children's Hospital/Texas Transplant Institute
    San Antonio Texas 78229 United States